155 related articles for article (PubMed ID: 16328053)
1. Potential prognostic and therapeutic roles for cytokines in breast cancer (Review).
Rao VS; Dyer CE; Jameel JK; Drew PJ; Greenman J
Oncol Rep; 2006 Jan; 15(1):179-85. PubMed ID: 16328053
[TBL] [Abstract][Full Text] [Related]
2. Significance of interleukin-6 (IL-6) in breast cancer (review).
Knüpfer H; Preiss R
Breast Cancer Res Treat; 2007 Apr; 102(2):129-35. PubMed ID: 16927176
[TBL] [Abstract][Full Text] [Related]
3. Cytokines as potential tumour markers.
Chechlinska M; Kowalska M; Kaminska J
Expert Opin Med Diagn; 2008 Jun; 2(6):691-711. PubMed ID: 23495779
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
5. Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.
Gingras I; Azim HA; Ignatiadis M; Sotiriou C
Clin Adv Hematol Oncol; 2015 Jun; 13(6):372-82. PubMed ID: 26352893
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in breast cancer.
Nicolini A; Carpi A; Rossi G
Cytokine Growth Factor Rev; 2006 Oct; 17(5):325-37. PubMed ID: 16931107
[TBL] [Abstract][Full Text] [Related]
7. Advancing Immunotherapy in Metastatic Breast Cancer.
Mansour M; Teo ZL; Luen SJ; Loi S
Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250
[TBL] [Abstract][Full Text] [Related]
8. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-10 in breast cancer.
Hamidullah ; Changkija B; Konwar R
Breast Cancer Res Treat; 2012 May; 133(1):11-21. PubMed ID: 22057973
[TBL] [Abstract][Full Text] [Related]
10. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
11. The role of inflammation in progression of breast cancer: Friend or foe? (Review).
Allen MD; Jones LJ
Int J Oncol; 2015 Sep; 47(3):797-805. PubMed ID: 26165857
[TBL] [Abstract][Full Text] [Related]
12. [Tumor markers of breast cancer].
Sławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2004 Jul; 58():292-300. PubMed ID: 15280799
[TBL] [Abstract][Full Text] [Related]
13. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
14. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
[TBL] [Abstract][Full Text] [Related]
15. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
16. The Role of Exercise and Hyperlipidaemia in Breast Cancer Progression.
Buss LA; Dachs GU
Exerc Immunol Rev; 2018; 24():10-25. PubMed ID: 29461968
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-6 and IL-12 levels in breast cancer patients.
Hussein MZ; Al Fikky A; Abdel Bar I; Attia O
Egypt J Immunol; 2004; 11(2):165-70. PubMed ID: 16734129
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer.
Fuksiewicz M; Kowalska M; Kotowicz B; Rubach M; Chechlinska M; Pienkowski T; Kaminska J
Clin Chem Lab Med; 2010 Oct; 48(10):1481-6. PubMed ID: 20578967
[TBL] [Abstract][Full Text] [Related]
19. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory biomarkers and bladder cancer prognosis: a systematic review.
Masson-Lecomte A; Rava M; Real FX; Hartmann A; Allory Y; Malats N
Eur Urol; 2014 Dec; 66(6):1078-91. PubMed ID: 25151017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
